Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Stroke

  Free Subscription


Articles published in J Am Coll Cardiol

Retrieve available abstracts of 111 articles:
HTML format
Text format



Single Articles


    November 2017
  1. WEITZ JI, Fredenburgh JC, Eikelboom JW
    A Test in Context: D-Dimer.
    J Am Coll Cardiol. 2017;70:2411-2420.
    PubMed     Text format     Abstract available


    October 2017
  2. GOROG DA, Fayad ZA, Fuster V
    Arterial Thrombus Stability: Does It Matter and Can We Detect It?
    J Am Coll Cardiol. 2017;70:2036-2047.
    PubMed     Text format     Abstract available


    September 2017
  3. PAQUETTE M, Riou Franca L, Teutsch C, Diener HC, et al
    Persistence With Dabigatran Therapy at 2 Years in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2017;70:1573-1583.
    PubMed     Text format     Abstract available


    August 2017
  4. MAGNUSON EA, Li H, Wang K, Vilain K, et al
    Cost-Effectiveness of Long-Term Ticagrelor in Patients With Prior Myocardial Infarction: Results From the PEGASUS-TIMI 54 Trial.
    J Am Coll Cardiol. 2017;70:527-538.
    PubMed     Text format     Abstract available


    June 2017
  5. LEE CJ, Pallisgaard JL, Olesen JB, Carlson N, et al
    Antithrombotic Therapy and First Myocardial Infarction in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2017;69:2901-2909.
    PubMed     Text format     Abstract available


  6. YAO X, Shah ND, Sangaralingham LR, Gersh BJ, et al
    Non-Vitamin K Antagonist Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Renal Dysfunction.
    J Am Coll Cardiol. 2017;69:2779-2790.
    PubMed     Text format     Abstract available


    May 2017
  7. MARZEC LN, Wang J, Shah ND, Chan PS, et al
    Influence of Direct Oral Anticoagulants on Rates of Oral Anticoagulation for Atrial Fibrillation.
    J Am Coll Cardiol. 2017;69:2475-2484.
    PubMed     Text format     Abstract available


  8. SARDAR P, Chatterjee S, Aronow HD, Kundu A, et al
    Carotid Artery Stenting Versus Endarterectomy for Stroke Prevention: A Meta-Analysis of Clinical Trials.
    J Am Coll Cardiol. 2017;69:2266-2275.
    PubMed     Text format     Abstract available


    March 2017
  9. KONSTANTINIDES SV, Vicaut E, Danays T, Becattini C, et al
    Impact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary Embolism.
    J Am Coll Cardiol. 2017;69:1536-1544.
    PubMed     Text format     Abstract available


  10. DE CATERINA R, Renda G, Carnicelli AP, Nordio F, et al
    Valvular Heart Disease Patients on Edoxaban or Warfarin in the ENGAGE AF-TIMI 48 Trial.
    J Am Coll Cardiol. 2017;69:1372-1382.
    PubMed     Text format     Abstract available


  11. RENDA G, Ricci F, Giugliano RP, De Caterina R, et al
    Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Disease.
    J Am Coll Cardiol. 2017;69:1363-1371.
    PubMed     Text format     Abstract available


    February 2017
  12. ZHAO DF, Edelman JJ, Seco M, Bannon PG, et al
    Coronary Artery Bypass Grafting With and Without Manipulation of the Ascending Aorta: A Network Meta-Analysis.
    J Am Coll Cardiol. 2017;69:924-936.
    PubMed     Text format     Abstract available


  13. HUISMAN MV, Rothman KJ, Paquette M, Teutsch C, et al
    The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2.
    J Am Coll Cardiol. 2017;69:777-785.
    PubMed     Text format     Abstract available


    January 2017
  14. CAHILL TJ, Baddour LM, Habib G, Hoen B, et al
    Challenges in Infective Endocarditis.
    J Am Coll Cardiol. 2017;69:325-344.
    PubMed     Text format     Abstract available


  15. BYUN YS, Yang X, Bao W, DeMicco D, et al
    Oxidized Phospholipids on Apolipoprotein B-100 and Recurrent Ischemic Events Following Stroke or Transient Ischemic Attack.
    J Am Coll Cardiol. 2017;69:147-158.
    PubMed     Text format     Abstract available


  16. VAN DIEPEN S, Fuster V, Verma S, Hamza TH, et al
    Dual Antiplatelet Therapy Versus Aspirin Monotherapy in Diabetics With Multivessel Disease Undergoing CABG: FREEDOM Insights.
    J Am Coll Cardiol. 2017;69:119-127.
    PubMed     Text format     Abstract available


    December 2016
  17. GOMEZ-OUTES A, Lagunar-Ruiz J, Terleira-Fernandez AI, Calvo-Rojas G, et al
    Causes of Death in Anticoagulated Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2016;68:2508-2521.
    PubMed     Text format     Abstract available


    November 2016
  18. GUREWICH V
    Therapeutic Fibrinolysis: How Efficacy and Safety Can Be Improved.
    J Am Coll Cardiol. 2016;68:2099-2106.
    PubMed     Text format     Abstract available


  19. ELGENDY I, Mahmoud A, Bavry A
    TCT-194 Is routine aspiration thrombectomy associated with a higher risk of stroke? A meta-analysis of randomized trials.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  20. LARSON D, Garberich R, Lips D, Burke MN, et al
    TCT-173 Safety of Very Early (< 3hrs) Routine Percutaneous Coronary Intervention after Fibrinolysis in ST-segment Elevation Myocardial Infarction.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  21. KOIFMAN E, Garcia-Garcia HM, Kiramijyan S, Negi S, et al
    TCT-153 Acute Stroke During Primary Percutaneous Coronary Intervention For ST Elevation Myocardial Infarction.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  22. GUTTMANN O, Perera D, Jain A, Mathur A, et al
    TCT-146 Routine Aspiration thrombectomy is associated with increased stroke rates during primary percutaneous coronary intervention for myocardial infarction.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  23. VERGARA R, Valenti R, Migliorini A, Parodi G, et al
    TCT-145 Rheolytic Thrombectomy for Acute Myocardial Infarction Complicated by Cardiogenic Shock.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


    October 2016
  24. LLOYD-JONES DM, Huffman MD, Karmali KN, Sanghavi DM, et al
    Estimating Longitudinal Risks and Benefits From Cardiovascular Preventive Therapies Among Medicare Patients: The Million Hearts Longitudinal ASCVD Risk Assessment Tool.
    J Am Coll Cardiol. 2016 Oct 28. pii: S0735-1097(16)36692.
    PubMed     Text format     Abstract available


  25. REDDY VY, Gibson DN, Kar S, O'Neill W, et al
    Post-FDA Approval, Initial US Clinical Experience with Watchman Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation.
    J Am Coll Cardiol. 2016 Oct 27. pii: S0735-1097(16)36641.
    PubMed     Text format     Abstract available


    September 2016
  26. LAU YC, Proietti M, Guiducci E, Blann AD, et al
    Atrial Fibrillation and Thromboembolism in Patients With Chronic Kidney Disease.
    J Am Coll Cardiol. 2016;68:1452-64.
    PubMed     Text format     Abstract available


  27. CHAN YH, Kuo CT, Yeh YH, Chang SH, et al
    Thromboembolic, Bleeding, and Mortality Risks of Rivaroxaban and Dabigatran in Asians With Nonvalvular Atrial Fibrillation.
    J Am Coll Cardiol. 2016;68:1389-401.
    PubMed     Text format     Abstract available


  28. GOSMANOVA EO, Mikkelsen MK, Molnar MZ, Lu JL, et al
    Association of Systolic Blood Pressure Variability With Mortality, Coronary Heart Disease, Stroke, and Renal Disease.
    J Am Coll Cardiol. 2016;68:1375-86.
    PubMed     Text format     Abstract available


  29. ALEXOPOULOS D, Xanthopoulou I, Moulias A, Lekakis J, et al
    Long-Term P2Y12-Receptor Antagonists in Post-Myocardial Infarction Patients: Facing a New Trilemma?
    J Am Coll Cardiol. 2016;68:1223-32.
    PubMed     Text format     Abstract available


  30. STEFFEL J, Giugliano RP, Braunwald E, Murphy SA, et al
    Edoxaban Versus Warfarin in Atrial Fibrillation Patients at Risk of Falling: ENGAGE AF-TIMI 48 Analysis.
    J Am Coll Cardiol. 2016;68:1169-78.
    PubMed     Text format     Abstract available


    August 2016
  31. BANSILAL S, Castellano JM, Garrido E, Wei HG, et al
    Assessing the Impact of Medication Adherence on Long-Term Cardiovascular Outcomes.
    J Am Coll Cardiol. 2016;68:789-801.
    PubMed     Text format     Abstract available


  32. AUFFRET V, Regueiro A, Del Trigo M, Abdul-Jawad Altisent O, et al
    Predictors of Early Cerebrovascular Events in Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement.
    J Am Coll Cardiol. 2016;68:673-84.
    PubMed     Text format     Abstract available


  33. KABRA R, Girotra S, Vaughan Sarrazin M
    Refining Stroke Prediction in Atrial Fibrillation Patients by Addition of African-American Ethnicity to CHA2DS2-VASc Score.
    J Am Coll Cardiol. 2016;68:461-70.
    PubMed     Text format     Abstract available


    June 2016
  34. HSU JC, Maddox TM, Kennedy K, Katz DF, et al
    Aspirin Instead of Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Risk for Stroke.
    J Am Coll Cardiol. 2016;67:2913-23.
    PubMed     Text format     Abstract available


  35. KO MJ, Jo AJ, Park CM, Kim HJ, et al
    Level of Blood Pressure Control and Cardiovascular Events: SPRINT Criteria Versus the 2014 Hypertension Recommendations.
    J Am Coll Cardiol. 2016;67:2821-31.
    PubMed     Text format     Abstract available


    May 2016
  36. MODY P, Joshi PH, Khera A, Ayers CR, et al
    Beyond Coronary Calcification, Family History, and C-Reactive Protein: Cholesterol Efflux Capacity and Cardiovascular Risk Prediction.
    J Am Coll Cardiol. 2016;67:2480-7.
    PubMed     Text format     Abstract available


  37. VRANCKX P, White HD, Huang Z, Mahaffey KW, et al
    Validation of BARC Bleeding Criteria in Patients With Acute Coronary Syndromes: The TRACER Trial.
    J Am Coll Cardiol. 2016;67:2135-44.
    PubMed     Text format     Abstract available


  38. RANA JS, Tabada GH, Solomon MD, Lo JC, et al
    Accuracy of the Atherosclerotic Cardiovascular Risk Equation in a Large Contemporary, Multiethnic Population.
    J Am Coll Cardiol. 2016;67:2118-30.
    PubMed     Text format     Abstract available


    April 2016
  39. EVANS M, Carrero JJ, Szummer K, Akerblom A, et al
    Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Myocardial Infarction Patients With Renal Dysfunction.
    J Am Coll Cardiol. 2016;67:1687-97.
    PubMed     Text format     Abstract available


  40. VADUGANATHAN M, Bhatt DL, Cryer BL, Liu Y, et al
    Proton-Pump Inhibitors Reduce Gastrointestinal Events Regardless of Aspirin Dose in Patients Requiring Dual Antiplatelet Therapy.
    J Am Coll Cardiol. 2016;67:1661-71.
    PubMed     Text format     Abstract available


  41. KARIO K, Saito I, Kushiro T, Teramukai S, et al
    Morning Home Blood Pressure Is a Strong Predictor of Coronary Artery Disease: The HONEST Study.
    J Am Coll Cardiol. 2016;67:1519-27.
    PubMed     Text format     Abstract available


  42. HERTTUA K, Martikainen P, Batty GD, Kivimaki M, et al
    Poor Adherence to Statin and Antihypertensive Therapies as Risk Factors for Fatal Stroke.
    J Am Coll Cardiol. 2016;67:1507-15.
    PubMed     Text format     Abstract available


    March 2016
  43. DEEB GM, Reardon MJ, Chetcuti S, Patel HJ, et al
    Three-Year Outcomes in High-Risk Patients Who Underwent Surgical or Transcatheter Aortic Valve Replacement.
    J Am Coll Cardiol. 2016 Mar 22. pii: S0735-1097(16)01690.
    PubMed     Text format     Abstract available


  44. LOVE BA, Diener HC
    PFO: "Please Figure Out," or Now "Potentially Figured Out?".
    J Am Coll Cardiol. 2016;67:918-20.
    PubMed     Text format    


  45. KENT DM, Dahabreh IJ, Ruthazer R, Furlan AJ, et al
    Device Closure of Patent Foramen Ovale After Stroke: Pooled Analysis of Completed Randomized Trials.
    J Am Coll Cardiol. 2016;67:907-17.
    PubMed     Text format     Abstract available


    February 2016
  46. MARIAN AJ
    Genetic Causality in Complex Traits: The Case of Uric Acid.
    J Am Coll Cardiol. 2016;67:417-9.
    PubMed     Text format    


  47. KEENAN T, Zhao W, Rasheed A, Ho WK, et al
    Causal Assessment of Serum Urate Levels in Cardiometabolic Diseases Through a Mendelian Randomization Study.
    J Am Coll Cardiol. 2016;67:407-16.
    PubMed     Text format     Abstract available


    January 2016
  48. PHILIPPART R, Brunet-Bernard A, Clementy N, Bourguignon T, et al
    CHA2DS2-VASc Score for Predicting Stroke and Thromboembolism in Patients With AF and Biological Valve Prosthesis.
    J Am Coll Cardiol. 2016;67:343-4.
    PubMed     Text format    


  49. BLOOMGARDEN Z, Bansilal S
    A Diabetes-Atrial Fibrillation Conundrum: Does Duration Trump Glycemia?
    J Am Coll Cardiol. 2016;67:248-50.
    PubMed     Text format    


  50. ASHBURNER JM, Go AS, Chang Y, Fang MC, et al
    Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.
    J Am Coll Cardiol. 2016;67:239-47.
    PubMed     Text format     Abstract available


  51. MILLWOOD IY, Bennett DA, Walters RG, Clarke R, et al
    Lipoprotein-Associated Phospholipase A2 Loss-of-Function Variant and Risk of Vascular Diseases in 90,000 Chinese Adults.
    J Am Coll Cardiol. 2016;67:230-1.
    PubMed     Text format    


  52. MASOUDI FA, Calkins H, Kavinsky CJ, Drozda JP Jr, et al
    Reply: Left Atrial Appendage Occlusion Device Societal Overview: The Surgeon's Comment.
    J Am Coll Cardiol. 2016;67:125.
    PubMed     Text format    


  53. EMMERT MY, Salzberg SP
    Left Atrial Appendage Occlusion Device Societal Overview: The Surgeon's Comment.
    J Am Coll Cardiol. 2016;67:124.
    PubMed     Text format    


    November 2015
  54. VAN SLOTEN TT, Sedaghat S, Laurent S, London GM, et al
    Carotid Stiffness Is Associated With Incident Stroke: A Systematic Review and Individual Participant Data Meta-Analysis.
    J Am Coll Cardiol. 2015;66:2116-25.
    PubMed     Text format     Abstract available


  55. PRASAD M, Lerman LO, Lerman A
    Carotid stiffness and cerebrovascular disease: the physiology beyond the anatomy.
    J Am Coll Cardiol. 2015;66:2126-8.
    PubMed     Text format    


  56. HOLMES DR JR
    Reply: Left Atrial Appendage Occlusion Devices Versus Pharmacological Agents for Stroke Prevention in Atrial Fibrillation.
    J Am Coll Cardiol. 2015;66:2058.
    PubMed     Text format    


  57. MESSORI A, Trippoli S
    Left Atrial Appendage Occlusion Devices Versus Pharmacological Agents for Stroke Prevention in Atrial Fibrillation.
    J Am Coll Cardiol. 2015;66:2056-8.
    PubMed     Text format    


  58. WOLFF V, Zinchenko I, Quenardelle V, Rouyer O, et al
    Characteristics and Prognosis of Ischemic Stroke in Young Cannabis Users Compared With Non-Cannabis Users.
    J Am Coll Cardiol. 2015;66:2052-3.
    PubMed     Text format    


    October 2015
  59. CAMM AJ, Savelieva I
    Stroke Risk Stratification in Patients With Atrial Fibrillation: Comme Ci, Comme Ca, Plus Ca Change....
    J Am Coll Cardiol. 2015;66:1860-3.
    PubMed     Text format    


  60. VAN DEN HAM HA, Klungel OH, Singer DE, Leufkens HG, et al
    Comparative Performance of ATRIA, CHADS2, and CHA2DS2-VASc Risk Scores Predicting Stroke in Patients With Atrial Fibrillation: Results From a National Primary Care Database.
    J Am Coll Cardiol. 2015;66:1851-9.
    PubMed     Text format     Abstract available


    September 2015
  61. SAVINO JA 3RD, Halperin JL
    Age, Ethnicity, and Stroke Risk in Patients With Atrial Fibrillation: Another Stitch in the Patchwork.
    J Am Coll Cardiol. 2015;66:1348-9.
    PubMed     Text format    


  62. CHAO TF, Wang KL, Liu CJ, Lin YJ, et al
    Age Threshold for Increased Stroke Risk Among Patients With Atrial Fibrillation: A Nationwide Cohort Study From Taiwan.
    J Am Coll Cardiol. 2015;66:1339-47.
    PubMed     Text format     Abstract available


  63. OPIE LH
    A Proposal to Incorporate Trial Data Into a Hybrid American College of Cardiology/American Heart Association Algorithm for the Allocation of Statin Therapy in Primary Prevention.
    J Am Coll Cardiol. 2015;66:1412-3.
    PubMed     Text format    


  64. BONDE AN, Kamper AL, Olesen JB
    Reply: Clinical Benefit of Warfarin in Dialysis Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2015;66:1311.
    PubMed     Text format    


  65. CHAN PH, Siu CW
    Clinical Benefit of Warfarin in Dialysis Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2015;66:1310-1.
    PubMed     Text format    


  66. SAN ROMAN JA, Vilacosta I, Lopez J, Sarria C, et al
    Critical Questions About Left-Sided Infective Endocarditis.
    J Am Coll Cardiol. 2015;66:1068-76.
    PubMed     Text format     Abstract available


    August 2015
  67. HESS CN, Peterson ED, Peng SA, de Lemos JA, et al
    Use and Outcomes of Triple Therapy Among Older Patients With Acute Myocardial Infarction and Atrial Fibrillation.
    J Am Coll Cardiol. 2015;66:616-27.
    PubMed     Text format     Abstract available


    July 2015
  68. LIP GY, Skjoth F, Rasmussen LH, Nielsen PB, et al
    Net Clinical Benefit for Oral Anticoagulation, Aspirin, or No Therapy in Nonvalvular Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA2DS2-VASc Score (Beyond Sex).
    J Am Coll Cardiol. 2015;66:488-90.
    PubMed     Text format    


  69. WIDIMSKY P, Asil T, Abelson M, Koznar B, et al
    Direct Catheter-Based Thrombectomy for Acute Ischemic Stroke: Outcomes of Consecutive Patients Treated in Interventional Cardiology Centers in Close Cooperation With Neurologists.
    J Am Coll Cardiol. 2015;66:487-8.
    PubMed     Text format    


  70. MARCUS GM, Dewland TA
    Premature Atrial Contractions: A Wolf in Sheep's Clothing?
    J Am Coll Cardiol. 2015;66:242-4.
    PubMed     Text format    


  71. LARSEN BS, Kumarathurai P, Falkenberg J, Nielsen OW, et al
    Excessive Atrial Ectopy and Short Atrial Runs Increase the Risk of Stroke Beyond Incident Atrial Fibrillation.
    J Am Coll Cardiol. 2015;66:232-241.
    PubMed     Text format     Abstract available


  72. BAVARIA JE, Giri J
    Transcatheter Aortic Valve Replacement in Women: Confirming Translational Science or More Confounded Clinical Research?
    J Am Coll Cardiol. 2015;66:229-231.
    PubMed     Text format    


  73. O'CONNOR SA, Morice MC, Gilard M, Leon MB, et al
    Revisiting Sex Equality With Transcatheter Aortic Valve Replacement Outcomes: A Collaborative, Patient-Level Meta-Analysis of 11,310 Patients.
    J Am Coll Cardiol. 2015;66:221-228.
    PubMed     Text format     Abstract available


  74. THOURANI VH, Tsai L, Jensen H
    The Heart and the Head: Neurological Implications of Transcatheter Aortic Valve Replacement.
    J Am Coll Cardiol. 2015;66:218-220.
    PubMed     Text format    


  75. BOSMANS J, Bleiziffer S, Gerckens U, Wenaweser P, et al
    The Incidence and Predictors of Early- and Mid-Term Clinically Relevant Neurological Events After Transcatheter Aortic Valve Replacement in Real-World Patients.
    J Am Coll Cardiol. 2015;66:209-217.
    PubMed     Text format     Abstract available


    June 2015
  76. WAKS JW, Manning WJ
    Left Atrial Appendage Closure to Reduce the Risk of Thromboembolic Complications in Atrial Fibrillation: Pay Now and Possibly Pay Later?
    J Am Coll Cardiol. 2015;65:2624-7.
    PubMed     Text format    


  77. HOLMES DR JR, Doshi SK, Kar S, Price MJ, et al
    Left Atrial Appendage Closure as an Alternative to Warfarin for Stroke Prevention in Atrial Fibrillation: A Patient-Level Meta-Analysis.
    J Am Coll Cardiol. 2015;65:2614-23.
    PubMed     Text format     Abstract available


  78. MASOUDI FA, Calkins H, Kavinsky CJ, Drozda JP Jr, et al
    2015 ACC/HRS/SCAI Left Atrial Appendage Occlusion Device Societal Overview: A Professional Societal Overview from the American College of Cardiology, Heart Rhythm Society, and Society for Cardiovascular Angiography and Interventions.
    J Am Coll Cardiol. 2015 Jun 20. pii: S0735-1097(15)02852.
    PubMed     Text format    


  79. REARDON MJ, Adams DH, Kleiman NS, Yakubov SJ, et al
    2-Year Outcomes in Patients Undergoing Surgical or Self-Expanding Transcatheter Aortic Valve Replacement.
    J Am Coll Cardiol. 2015 Jun 2. pii: S0735-1097(15)02341.
    PubMed     Text format     Abstract available


    May 2015
  80. HIRSH BJ, Copeland-Halperin RS, Halperin JL
    Fibrotic Atrial Cardiomyopathy, Atrial Fibrillation, and Thromboembolism: Mechanistic Links and Clinical Inferences.
    J Am Coll Cardiol. 2015;65:2239-2251.
    PubMed     Text format     Abstract available


  81. WINDLE JR, Windle TA
    Electronic Health Records and the Quest to Achieve the "Triple Aim".
    J Am Coll Cardiol. 2015;65:1973-5.
    PubMed     Text format    


  82. JOYNT KE, Bhatt DL, Schwamm LH, Xian Y, et al
    Lack of impact of electronic health records on quality of care and outcomes for ischemic stroke.
    J Am Coll Cardiol. 2015;65:1964-72.
    PubMed     Text format     Abstract available


  83. MARON BJ, Rowin EJ, Casey SA, Link MS, et al
    Hypertrophic Cardiomyopathy in Adulthood Associated With Low Cardiovascular Mortality With Contemporary Management Strategies.
    J Am Coll Cardiol. 2015;65:1915-28.
    PubMed     Text format     Abstract available


    April 2015
  84. CHAO TF, Liu CJ, Chen SA
    Reply: one more "C" for CHA2DS2-VASc score.
    J Am Coll Cardiol. 2015;65:1603-4.
    PubMed     Text format    


  85. SIU CW
    One more "C" for CHA2DS2-VASc score?
    J Am Coll Cardiol. 2015;65:1602-3.
    PubMed     Text format    


  86. BABER U, Halperin JL
    Variability in low-density lipoprotein cholesterol and cardiovascular risk: should consistency be a new target?
    J Am Coll Cardiol. 2015;65:1549-51.
    PubMed     Text format    


  87. BANGALORE S, Breazna A, DeMicco DA, Wun CC, et al
    Visit-to-Visit Low-Density Lipoprotein Cholesterol Variability and Risk of Cardiovascular Outcomes: Insights From the TNT Trial.
    J Am Coll Cardiol. 2015;65:1539-48.
    PubMed     Text format     Abstract available


  88. LIP GY, Skjoth F, Rasmussen LH, Larsen TB, et al
    Oral anticoagulation, aspirin, or no therapy in patients with nonvalvular AF with 0 or 1 stroke risk factor based on the CHA2DS2-VASc score.
    J Am Coll Cardiol. 2015;65:1385-94.
    PubMed     Text format     Abstract available


  89. PRICE MJ
    The optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: chasing a mirage.
    J Am Coll Cardiol. 2015;65:1311-3.
    PubMed     Text format    


    March 2015
  90. CHATURVEDI S, Sacco RL
    How Recent Data Have Impacted the Treatment of Internal Carotid Artery Stenosis.
    J Am Coll Cardiol. 2015;65:1134-1143.
    PubMed     Text format     Abstract available


  91. KIRTANE AJ, Kelly CR
    Clearing the air on the "smoker's paradox".
    J Am Coll Cardiol. 2015;65:1116-8.
    PubMed     Text format    


  92. ZHANG YJ, Iqbal J, van Klaveren D, Campos CM, et al
    Smoking is associated with adverse clinical outcomes in patients undergoing revascularization with PCI or CABG: the SYNTAX trial at 5-year follow-up.
    J Am Coll Cardiol. 2015;65:1107-15.
    PubMed     Text format     Abstract available


  93. RIDKER PM, Rose L, Cook NR
    A proposal to incorporate trial data into a hybrid ACC/AHA algorithm for the allocation of statin therapy in primary prevention.
    J Am Coll Cardiol. 2015;65:942-8.
    PubMed     Text format     Abstract available


  94. HUISMAN MV
    Patients With Atrial Fibrillation and a CHADS-VASc Score of 1: Are They at Low or High Stroke Risk?
    J Am Coll Cardiol. 2015 Mar 5. pii: S0735-1097(15)00435.
    PubMed     Text format    


    February 2015
  95. CALKINS H
    Data Strengthen to Support Recommending Anticoagulant Therapy for All Atrial Fibrillation Patients With a CHADS-VASc Score >/=1.
    J Am Coll Cardiol. 2015;65:643-644.
    PubMed     Text format    


  96. CHAO TF, Liu CJ, Wang KL, Lin YJ, et al
    Should Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHADS-VASc Score (Beyond Sex) Receive Oral Anticoagulation?
    J Am Coll Cardiol. 2015;65:635-642.
    PubMed     Text format     Abstract available


  97. GIUSTINO G, Baber U, Sartori S, Mehran R, et al
    Duration of Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    J Am Coll Cardiol. 2015 Feb 7. pii: S0735-1097(15)00345.
    PubMed     Text format     Abstract available


  98. YANKELSON L, Steinvil A, Adler A, Viskin S, et al
    Reply: life-threatening events during endurance sports: is heat stroke more prevalent than arrhythmic death?
    J Am Coll Cardiol. 2015;65:408-9.
    PubMed     Text format    


  99. SCHERR J, Halle M
    Heat stroke versus cardiac events: a matter of strain duration and climate conditions.
    J Am Coll Cardiol. 2015;65:408.
    PubMed     Text format    


    January 2015
  100. CHEN-SCARABELLI C, Scarabelli TM, Ellenbogen KA, Halperin JL, et al
    Device-Detected Atrial Fibrillation: What to Do With Asymptomatic Patients?
    J Am Coll Cardiol. 2015;65:281-294.
    PubMed     Text format     Abstract available


  101. SINGER DE, Ezekowitz MD
    Adding rigor to stroke risk prediction in atrial fibrillation.
    J Am Coll Cardiol. 2015;65:233-5.
    PubMed     Text format    


  102. FRIBERG L, Skeppholm M, Terent A
    Benefit of Anticoagulation Unlikely in Patients With Atrial Fibrillation and a CHA2DS2-VASc Score of 1.
    J Am Coll Cardiol. 2015;65:225-32.
    PubMed     Text format     Abstract available


    December 2014
  103. OEMRAWSINGH RM, Cheng JM, Garcia-Garcia HM, van Geuns RJ, et al
    Near-infrared spectroscopy predicts cardiovascular outcome in patients with coronary artery disease.
    J Am Coll Cardiol. 2014;64:2510-8.
    PubMed     Text format     Abstract available


  104. BALL T, Wheelan K, McCullough PA
    Chronic anticoagulation in chronic kidney disease.
    J Am Coll Cardiol. 2014;64:2483-5.
    PubMed     Text format    


  105. BONDE AN, Lip GY, Kamper AL, Hansen PR, et al
    Net Clinical Benefit of Antithrombotic Therapy in Patients With Atrial Fibrillation and Chronic Kidney Disease: A Nationwide Observational Cohort Study.
    J Am Coll Cardiol. 2014;64:2471-82.
    PubMed     Text format     Abstract available


  106. HART RG, Halperin JL, Weitz JI
    Vorapaxar, combination antiplatelet therapy, and stroke.
    J Am Coll Cardiol. 2014;64:2327-9.
    PubMed     Text format    


  107. BONACA MP, Scirica BM, Braunwald E, Wiviott SD, et al
    New ischemic stroke and outcomes with vorapaxar versus placebo: results from the TRA 2 degrees P-TIMI 50 trial.
    J Am Coll Cardiol. 2014;64:2318-26.
    PubMed     Text format     Abstract available


  108. BONACA MP, Scirica BM, Braunwald E, Wiviott SD, et al
    Coronary Stent Thrombosis With Vorapaxar Versus Placebo: Results From the TRA 2 degrees P-TIMI 50 Trial.
    J Am Coll Cardiol. 2014;64:2309-17.
    PubMed     Text format     Abstract available


  109. WEBB J, Gerosa G, Lefevre T, Leipsic J, et al
    Multicenter evaluation of a next-generation balloon-expandable transcatheter aortic valve.
    J Am Coll Cardiol. 2014;64:2235-43.
    PubMed     Text format     Abstract available


  110. BORDEN WB, Maddox TM, Tang F, Rumsfeld JS, et al
    Impact of the 2014 Expert Panel Recommendations for Management of High Blood Pressure on Contemporary Cardiovascular Practice: Insights From the NCDR PINNACLE Registry.
    J Am Coll Cardiol. 2014;64:2196-203.
    PubMed     Text format     Abstract available


    November 2014
  111. SPAZIANO M, Francese DP, Leon MB, Genereux P, et al
    Imaging and Functional Testing to Assess Clinical and Subclinical Neurological Events After Transcatheter or Surgical Aortic Valve Replacement: A Comprehensive Review.
    J Am Coll Cardiol. 2014;64:1950-1963.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Stroke is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: